1. Figure 4 Cerebrospinal fluid levels of neurofilament light chain
Figure 4 | Cerebrospinal fluid levels of neurofilament light chain. a | Cerebrospinal fluid (CSF) levels of neurofilament light chain (NfL) in clinical frontotemporal dementia (FTD) subtypes and other neurodegenerative diseases; horizontal lines represent medians. b | Kaplan–Meier survival curves stratified for CSF NfL levels in tertiles; vertical ticks represent censored data (patients known to be alive at that time from CSF collection). c | CSF levels of NfL in presymptomatic and symptomatic genetic FTD of the three major genes (GRN, C9orf72 and MAPT), including two individuals who converted from the presymptomatic to symptomatic stage (connecting line). AD, Alzheimer disease; bvFTD, behavioural variant frontotemporal dementia; CBS, corticobasal syndrome; MND, motor neuron disease; nfvPPA, nonfluent variant primary progressive aphasia; PD, Parkinson disease; PSP, progressive supranuclear palsy; svPPA, semantic variant primary progressive aphasia. Part a modified with permission from Wiley & Sons © Scherling, C. S. et al. Ann. Neurol. 75, 116–126 (2014). Parts b–c modified with permission from Wiley & Sons © Meeter, L. H. et al. Ann. Clin. Transl. Neurol. 3, 623–636 (2016) under a Creative Commons license.
Part a modified with permission from Wiley & Sons © Scherling, C. S. et al. Ann.
Neurol. 75, 116–126 (2014). Parts b–c modified with permission from Wiley & Sons ©
Meeter, L. H. et al. Ann. Clin. Transl. Neurol. 3, 623–636 (2016) under a Creative Commons license.
Meeter, L. H. et al. (2017) Imaging and fluid biomarkers in frontotemporal dementia
Nat. Rev. Neurol. doi: /nrneurol